.Merck trumps profits desires, raises sales overview on strong requirement for top drugs like Keytruda CNBCMerck & Co. (MRK United States) Beats Income Estimates as Keytruda Purchases Rise BloombergMerck Inventory: Pharma Titan Posts Powerful Outcomes, But Outlook Tumbles Short Real estate investor's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats income and sales expectations surrounded by Keytruda strength, yet gives combined full-year outlook MarketWatch.